JP Nadda addresses rising cancer cases, medicine affordability
New Delhi: Amid rising cancer cases in India, Health Minister JP Nadda ensured that the government is committed to providing affordable and accessible treatment. The Minister said this while replying to a supplementary questions during Question Hour in the Lok Sabha.
Nadda also noted that cancer cases are increasing annually by nearly 2.5 percent.
In men, cases of oral and lung cancer are on the up while more women are getting breast cancer, he added.
More than 15.5 lakh cancer cases are being registered every year, Nadda said.
"There is a list of 131 essential cancer medicines, which are in Schedule 1, (that) are monitored and (their) pricing is decided by the government. These are the commonly used medicines," Nadda said.
According to PTI, he said patients cumulatively saved around Rs 294 crore due to this price control.
"There are 28 combinations, which are not in this list but the NPPA (National Pharmaceutical Pricing Authority) and the government have controlled their pricing as well," he said.
"We have tried to make cancer drugs affordable," he added.
Responding to another question on healthcare infrastructure, Nadda said the government was apprised of the matter and expansion of medical colleges were happening so that there could be more doctors.
"There should be a balance in quality and quantity of medical education. We are trying to go as fast as we can but, at the same time, (we) do not want to compromise on the quality of medical doctors," he said.
Nadda informed the House that the number of medical colleges had gone up from 387 in 2014 to 731 at present while the number of MBBS seats rose from 51,348 seats to 1,12,112 (1.12 lakh) during the same period.
The number of postgraduate seats for medical students has gone up from 31,185 in 2014 to 72,627 at present, he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd